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ABSTRACT Staphylococcus aureus is a major human pathogen, and the emergence
of antibiotic-resistant strains is making all types of S. aureus infections more chal-
lenging to treat. With a pressing need to develop alternative control strategies to
use alongside or in place of conventional antibiotics, one approach is the targeting
of established virulence factors. However, attempts at this have had little success to
date, suggesting that we need to better understand how this pathogen causes dis-
ease if effective targets are to be identified. To address this, using a functional
genomics approach, we have identified a small membrane-bound protein that we
have called MspA. Inactivation of this protein results in the loss of the ability of S.
aureus to secrete cytolytic toxins, protect itself from several aspects of the human
innate immune system, and control its iron homeostasis. These changes appear to
be mediated through a change in the stability of the bacterial membrane as a con-
sequence of iron toxicity. These pleiotropic effects on the ability of the pathogen to
interact with its host result in significant impairment in the ability of S. aureus to
cause infection in both a subcutaneous and sepsis model of infection. Given the
scale of the effect the inactivation of MspA causes, it represents a unique and prom-
ising target for the development of a novel therapeutic approach.
KEYWORDS Staphylococcus aureus, cytotoxins, immune evasion, iron homeostasis,
virulence
Staphylococcus aureus is a major human pathogen, where the types of infections itcauses range in severity from relatively superficial skin and soft-tissue infections
(SSTIs) to fatal cases of endocarditis and bacteremia (1, 2). While SSTIs rarely require
clinical intervention, more invasive or prolonged infections require antibiotic treatment.
Unfortunately, the widespread use of antibiotics has given rise to the emergence of
antibiotic-resistant strains of S. aureus, including the notorious methicillin-resistant S.
aureus (MRSA), which at its peak was reported to be responsible for in excess of 50%
of S. aureus infections in hospitals (3). Infection control measures and changes to
antibiotic usage policies have led to a decrease in the incidence of MRSA in several
countries. In England, where the surveillance of S. aureus bacteremia is mandatory, the
incidence of MRSA declined for several years (by 80% since 2007) (4). However, the
incidence of methicillin-sensitive S. aureus (MSSA) bacteremia has increased year on
year, having the effect of increasing the overall incidence of S. aureus bacteremia by
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30.3% since 2011, when mandatory surveillance began (4), a worrying trend that has
also been observed in other countries (5, 6). Although new classes of antibiotics are
under development, given the rate at which S. aureus evolves resistance, it is clear that
we need to improve our understanding of this pathogen to develop alternative
therapeutic strategies.
One approach is to target specific virulence factors through either vaccination or
molecular inhibition. To identify and develop such strategies, we need to have a
thorough understanding of the pathogenicity of S. aureus, which to date has largely
been informed by the analysis of a small number of laboratory strains that have been
passaged in vitro many times. This work has enabled us to identify and characterize
many of the strategies S. aureus uses to cause disease, which, generally speaking, can
be split into three categories: adhesion (7), the ability to bind and invade host tissue;
toxicity (8), which we describe here as the secretion of proteins that cause host tissue
damage; and evasion (9), the ability to neutralize or circumvent the protective activity
of the host immune system. Although many specific virulence factors display just one
of these three activities, many have multiple activities resulting in them belonging to
two and sometimes all three categories, producing a complex picture of how this
common member of our normal flora can cause life-threatening disease.
To better understand the pathogenicity of S. aureus, we developed a functional
genomics approach to make use of the many thousands of clinical S. aureus isolates
that have been sequenced (10–12). This has enabled us to identify novel loci that affect
the ability of S. aureus to both secrete cytolytic toxins and form biofilm (10–12). One
such gene, which was annotated as encoding a putative membrane-bound protein,
MspA, is the focus of this study. Here, we present our characterization of the in vitro and
in vivo properties of the MspA protein, where we have found it to affect many diverse,
membrane protein-mediated S. aureus activities. Inactivation of MspA affects toxin
production, resistance to innate immune mechanisms, and iron homeostasis, resulting
in complete attenuation of this pathogen in both a superficial and invasive model of
infection. As such, it represents a promising target for therapeutic development and
warrants further investigation.
RESULTS
The MspA protein positively affects the production of cytolytic toxins by S.
aureus. In previous work, we found an association between a gene with the locus tag
SATW20_23930 in the TW20 MRSA background (13) and the ability of clinical strains to
lyse human cells (10). We have named the gene mspA, for membrane stabilizing protein
A, as our data (presented later) suggest it plays a role in the membrane stability of the
bacteria. With the availability of a transposon library in the USA300 MRSA background,
we sought this gene and found that it was misannotated in the FPR3757 background
as intergenic between SAUSA300_2212 and SAUSA300_2213 (14). We were, however,
able to obtain transposon mutants in this region from the Nebraska Transposon Mutant
Library (NTML) (15), where we found that inactivation of this gene reduced the ability
of the bacteria to lyse THP-1 cells, which is an immortalized cell line that is sensitive to
the majority of the cytolytic toxins expressed by S. aureus (11, 12) (Fig. 1a). This effect
on toxicity was complemented by expressing the mspA gene from an inducible
promoter on the pRMC2 plasmid (16) (Fig. 1a). To confirm the effect was not specific to
this genetic background, we transduced the transposon insertion into a genetically
distinct methicillin-sensitive S. aureus (MSSA) strain, SH1000 (17), where again it re-
sulted in the loss of cytolytic activity for the bacteria (Fig. 1b). The effect on toxicity was
further confirmed on A549 cells (Fig. 1c) (18) and human red blood corpuscles (Fig. 1d),
which contain the additional receptors for S. aureus toxins not present on THP-1 cells,
demonstrating the widespread effect the loss of this protein has on cytolytic toxin
secretion by both MRSA and MSSA. The effect on toxin production was not due to
differences in growth dynamics between wild-type and mspA mutants (see Fig. S1 in
the supplemental material).
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FIG 1 Inactivation of the mspA gene results in a loss of toxicity (cytolytic activity) for S. aureus. (a and b) In
both the JE2 (a) and SH1000 (b) backgrounds, the inactivation of mspA resulted in a loss of cytolytic activity,
represented by a significant decrease in cell death. The loss of cytolytic activity was complemented in both
backgrounds by expressing the mspA gene from a plasmid (pmspA). (c and d) Furthermore, the inactivation
of mspA resulted in a loss of toxicity to a lung epithelial cell line (A549) (c) and human red blood corpuscles
(d) in both the JE2 and SH1000 backgrounds. Inactivation of mspA also resulted in a reduction in the
(Continued on next page)
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We next quantified the effect the inactivation of MspA has on the expression of
several toxins to confirm whether its activity was specific to a single S. aureus toxin or
had a more general effect. In both the JE2 and SH1000 background, the inactivation of
mspA resulted in a decrease in alpha toxin (Hla) secretion, as demonstrated by Western
blotting of bacterial supernatant (Fig. 1e and Fig. S2). There is also a reduction in the
secretion of several of the phenol-soluble modulins, including delta toxin, which was
determined by high-performance liquid chromatography-mass spectrometry (HPLC-
MS) (19) (Fig. 1f). For both alpha toxin and the phenol-soluble modulins (PSMs), the
effect of the inactivation of mspA was more pronounced in the SH1000 background.
Given the effect on the production of all these toxins, we hypothesized that the effect
of the inactivation of mspA was mediated by the repression or lack of activation of the
major regulator of toxin expression, the accessory gene regulatory (Agr) quorum-
sensing system (20). To test this, we quantified the transcription of the regulatory RNA
effector molecule of the Agr system, rnaIII, relative to the housekeeping gene sigA and
found this level to be significantly lower in the mspA mutants. This provides a likely
explanation for the effect we have observed of the loss of mspA on toxicity (Fig. 1g).
To better understand the activity of this protein, we examined both the genomic
location of the gene and the likely cellular location of the encoded protein. The mspA
gene is situated between a hypothetical protein (SAUSA300_2212) and an AcrB/AcrD/
AcrF family protein (SAUSA300_2213) (Fig. S3a). To understand the potential cellular
localization of the translated protein, we used the protein structure predicting software
Protter (21), which suggests that MspA is a membrane-bound protein with four
transmembrane domains, both the C and N termini are predicted to be exposed to the
outside on the membrane, and it lacks a recognized signal sequence (Fig. 1h). To
examine the role of the genes located to either side of the mspA gene, we quantified
the toxicity of transposon mutants in these genes in both the JE2 USA300 MRSA and
SH1000 MSSA backgrounds and found there to be no effect, with the exception of a
slight reduction in toxicity for NE42 (SAUSA300_2212) in the JE2 background (Fig. S3b),
suggesting that the genes to either side of mspA play a minimal role in the effect of
MspA on cytolytic toxin production.
Proteomic analysis reveals pleiotropic effects on the loss of mspA. To identify
changes in expression pathways that might explain how the MspA protein is affecting
the Agr system, we adopted a proteomic approach and used tandem mass tagging
coupled to mass spectroscopy (TMT-MS [22]) on whole-cell lysates of the JE2 strain and
its mspA mutant. Using the S. aureus USA300 proteome as our reference, we were able
to detect and quantify the abundance of 1,149 proteins. Using a 2-fold difference in
abundance and a P value of less than 0.05 as our cutoff for biological and statistical
significance, we found 63 proteins differentially abundant in the mspA mutant com-
pared to the wild-type strain (Table 1), demonstrating the pleiotropic effect the loss of
mspA has on the S. aureus proteome. Three particular differences were of note. The first
was that there was a 2.2-fold reduction in the abundance of CrtM (UniProt accession no.
Q2FV59), an enzyme involved in the biosynthesis of staphyloxanthin (23, 24). This
membrane-bound carotenoid is believed to work alongside the scaffold protein flotillin
(FloA) to help form stable functional membrane microdomains (FMMs) (25). While FloA
was detected in our analysis, there was no significant difference in its abundance
between the wild type and mspA mutant. The second observation was that a number
FIG 1 Legend (Continued)
abundance of alpha toxin in the bacterial supernatants in both backgrounds, determined by Western
blotting. (e) Densitometry values for triplicate blots are shown. (f) The effect of the inactivation of mspA on
secretion of PSMs was quantified by HPLC-MS, where the secretion of delta toxin was the most affected in
both backgrounds (P  0.001). AU, arbitrary units. (g) The activity of the Agr system is repressed by the
inactivation of mspA, as illustrated by qRT-PCR quantification of rnaIII transcription. (h) Protter (21) predicts
that MspA is a membrane-bound protein with four membrane-spanning domains. The dots represent
biological replicates, the bars represent the mean of the replicates, and the error bars are the standard
errors of the means. Statistics were performed using a one-way ANOVA, and significance was determined
as the following P values: *, 0.05; **, 0.01; ***, 0.001; ****, 0.0001.
Duggan et al. Infection and Immunity
September 2020 Volume 88 Issue 9 e00162-20 iai.asm.org 4
 on S
eptem







TABLE 1 Comparative proteomic analysis of whole-cell lysate derived from mspA mutant and wild-type strain JE2
Accession no.a Gene Functional description Fold changeb Abundancec P valued
Q2FVR0 hrtB Hemin transport system permease protein HrtB 18.0 1 0.0001
Q2G079 nrdl Protein NrdI 5.8 1 0.002
Q2G2P2 Globin domain protein 3.6 1 0.001
Q2FUQ9 Cold shock protein 3.5 1 0.027
Q2FX98 Uncharacterized protein 3.2 1 0.003
Q2FZX4 lipA Lipoyl synthase 2.7 1 0.0001
Q2FVR1 hrtA Hemin import ATP-binding protein HrtA 2.7 1 0.006
Q2G0T9 Alpha amylase family protein 2.7 1 0.003
Q2FXF4 Uncharacterized protein 2.7 1 0.037
Q2FZA9 arcC1 Carbamate kinase 1 2.6 1 0.0001
Q8KQR1 isdC Iron-regulated surface determinant protein C 2.6 1 0.002
P72360 scdA Iron-sulfur cluster repair protein ScdA 2.6 1 0.006
Q2G1N4 Periplasmic binding protein 2.5 1 0.008
Q2G1X0 hla Alpha-hemolysin 2.4 1 0.008
Q2FWY2 Pyrazinamidase/nicotinamidase 2.4 1 0.029
Q2FV74 clpL ATP-dependent Clp protease ATP-binding subunit 2.4 1 0.001
Q2G2R5 PTS system lactose-specific IIA component 2.3 1 0.003
Q2FW75 ABC transporter periplasmic binding protein 2.3 1 0.002
Q2FVE7 cntA Peptide ABC transporter, peptide-binding protein 2.3 1 0.004
Q2FWB7 Uncharacterized protein 2.2 1 0.021
Q2FYK3 cfvC Conserved virulence factor C 2.2 1 0.004
Q2FXE1 Uncharacterized protein 2.2 1 0.007
Q2FZB0 argF Ornithine carbamoyltransferase 2.2 1 0.0001
Q2FZJ9 qoxA Probable quinol oxidase subunit 2 2.2 1 0.006
Q2FVF9 Uncharacterized protein 2.1 1 0.034
Q2FV17 fda Fructose-bisphosphate aldolase class 1 2.1 1 0.0001
Q2FZF0 isdB Iron-regulated surface determinant protein B 2.1 1 0.080
Q2G1Z3 Iron compound ABC transporter 2.1 1 0.002
Q2FYN6 Uncharacterized hydrolase 2.0 2 0.155
Q2G0L5 sdrC Serine-aspartate repeat-containing protein C 2.0 2 0.001
Q2G0W6 Uncharacterized protein 2.1 2 0.006
Q2FUU5 lipA Lipase 1 2.1 2 0.002
Q2FWZ8 ftnA Bacterial nonheme ferritin 2.1 2 0.001
Q2G294 Acetyl-coenzyme A synthetase 2.1 2 0.001
Q2FZI6 purH Bifunctional purine biosynthesis protein PurH 2.2 2 0.0001
Q2FVS2 Uncharacterized protein 2.2 2 0.001
Q2G2P7 hutH Histidine ammonia-lyase 2.2 2 0.006
Q2FW51 Truncated major histocompatibility complex class II analog protein 2.2 2 0.015
Q2FVQ4 L-Lactate permease 2.2 2 0.006
Q2FV59 crtM Dehydrosqualene synthase 2.2 2 0.001
Q2FUX7 arcA Arginine deiminase 2.3 2 0.080
Q2FVE0 ahpD Alkyl hydroperoxide reductase AhpD 2.3 2 0.0001
Q2G1C7 Uncharacterized protein 2.3 2 0.006
Q2FZR3 Oligopeptide ABC transporter 2.3 2 0.004
Q2FZS2 Truncated major histocompatibility complex class II analog protein 2.4 2 0.004
Q2G0W8 Uncharacterized protein 2.4 2 0.008
Q2G2P5 nikA Nickel-binding protein 2.4 2 0.008
Q2FV34 Uncharacterized protein 2.5 2 0.001
Q2G118 parB Chromosome partitioning protein, ParB family 2.5 2 0.005
Q2G1I8 Uncharacterized protein 2.5 2 0.001
Q2FZS8 clpB Chaperone protein ClpB 2.5 2 0.001
Q2G087 hisC Histidinol-phosphate aminotransferase 2.6 2 0.047
Q2G1C9 Uncharacterized protein 2.6 2 0.0001
Q2G0G1 adh Alcohol dehydrogenase 2.8 2 0.017
Q2FWN9 Uncharacterized leukocidin-like protein 2 2.9 2 0.0001
Q2G1C8 Uncharacterized protein 3.0 2 0.0001
Q2G1D0 Acetyl-coenzyme A acetyltransferase 4.4 2 0.003
Q2G1K9 Aldehyde-alcohol dehydrogenase 4.6 2 0.001
Q2FWP0 Uncharacterized leukocidin-like protein 1 4.9 2 0.003
Q2FVJ5 bioD ATP-dependent dethiobiotin synthetase BioD 6.3 2 0.001
Q2G218 ish1 L-Lactate dehydrogenase 1 7.3 2 0.001
Q2G091 ABC transporter 9.4 2 0.0001
Q2FVJ7 bioB Biotin synthase 9.7 2 0.001
aAccession number corresponds to the protein identifier in the UniProt database.
bFold changes of proteins were determined by comparing changes to protein abundances in the JE2mspA::tn mutant relative to the level of the wild-type JE2 strain in
three independent experiments.
c1, Greater abundance in the mspA mutant relative to the level in the wild-type strain;2, lower abundance in the mspA mutant relative to the level in the wild-type strain.
dP values were calculated using Student’s t test.
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of proteins involved in both the uptake (e.g., IsdB and IsdC [26]) and efflux (HrtA and
HrtB [27]) of heme-iron were affected; however, there was no detectable difference in
the abundance of any other iron uptake or efflux proteins or in the ferric uptake
regulatory protein, Fur. Although the extent of the effect on the general response to
iron is still unclear, these data suggest that the ability of the bacteria to control iron
homeostasis is impaired in the mspA mutant. The third difference was a conflicting
result where Hla was more abundant in the whole-cell lysate of the mutant; however,
we demonstrate above that in the bacterial supernatant Hla is significantly less abun-
dant in the mutant (Fig. 1e), suggesting that protein secretion is affected by the loss of
MspA.
MspA mutant is more sensitive to innate immune attack. Staphyloxanthin plays
several defensive roles for S. aureus, including protection from reactive oxygen species,
fatty acids, and survival inside macrophage, and is believed to work alongside FloA to
help form FMMs (23–25). As the proteomic analysis suggested that CrtM (Q2FV59), an
enzyme involved in the biosynthesis of staphyloxanthin, was less abundant in the mspA
mutant, we sought to characterize this effect in greater detail. We first compared the
abundance of staphyloxanthin in the membranes of the wild types and mspA mutants
of both JE2 and SH1000 and in the crtM and floA mutants in the JE2 background. There
was a reduction in both mspA mutants; however, they still produced significantly more
staphyloxanthin than the crtM mutant (Fig. 2a). Given the protective role of staphylox-
anthin, we sought to examine whether its reduced abundance in the absence of MspA
rendered S. aureus more susceptible to innate immune attack. We first quantified S.
aureus resistance to the membrane-damaging effects of human defensin-1 (hNP-1) (28,
29) and oleic acid (30–32). Produced by neutrophils and other immune cells, hNP-1 kills
bacteria through pore formation driven by electrostatic attractions between these
cationic peptides and the negatively charged bacterial membrane (28, 29). Oleic acid is
the predominant bactericidal unsaturated fatty acid naturally present in staphylococcal
abscesses and on the skin surface (30–32). Its primary target is also the bacterial
membrane, where at high concentrations it increases membrane fluidity and causes
protein leakage and interference with metabolic pathways (30–32). The inactivation of
mspA in both S. aureus backgrounds significantly impaired survival against these innate
immune components (Fig. 2b to e). We also investigated bacterial survival inside
macrophages (phorbol 12-myristate 13-acetate [PMA]-differentiated THP-1 cells) (Fig.
2f) and following exposure to human blood (Fig. 2g). In both S. aureus backgrounds the
mspA mutants survived significantly less well than the wild-type strains.
The loss of MspA affects the stability of the bacterial membrane. Our data
demonstrate the importance of MspA to the ability of S. aureus to protect itself from the
innate immune system, potentially through its effect on staphyloxanthin production.
However, that other membrane-associated activities are also affected (i.e., Agr activity)
suggests that the loss of MspA has a more general effect on the membrane. To test
whether membrane stability was affected by the loss of MspA, we compared the
sensitivity of the bacteria to a range of concentrations of the detergent SDS, where we
found that the mspA mutant was significantly more sensitive to this than the wild-type
and crtM, floA, or agrA mutant strains (Fig. 3a). The mspA mutants in both backgrounds
were also less able to withstand penetration by the DNA-staining dye propidium iodide
(Fig. 3b and c), providing further evidence that the loss of MspA causes destabilization
of the bacterial membrane. This effect on the membrane may contribute to the
reduction in staphyloxanthin in the membrane as well as adding to the sensitization of
the membrane to the innate immune system through the reduction of staphyloxanthin
in the membrane.
Iron homeostasis is affected by the loss of MspA. S. aureus, like many other
pathogens, utilizes heme as a source of iron during infection (33). It can either capture
hemoglobin and release heme from this or synthesize it endogenously using the
enzymes encoded by the hem locus (34). However, heme can be toxic at high concen-
trations, so the balance between uptake, synthesis, and efflux is specifically regulated.
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FIG 2 MspA confers protection against aspects of innate immunity. (a) The carotenoid pigment staphyloxanthin is less
abundant in the membranes of both the crtM and mspA mutants than in those of both the wild-type strain and floA mutant
in the JE2 background. (b and c) Survival of S. aureus upon exposure to oleic acid was reduced in the mspA mutants in both
(Continued on next page)
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The second major observation from the proteomic analysis was that proteins involved
in both the uptake and efflux of heme-iron by the bacteria were dysregulated in the
mspA mutant, suggesting that bacterial iron homeostasis is impaired. To explore this
further, we compared the levels of intracellular iron in the wild-type and mutant strains
using the antibiotic streptonigrin, which causes nucleic acid damage in the presence of
iron (35). As such, quantifying the level of sensitivity of a bacterium to this antibiotic can
be used as an indication of the relative amounts of iron present in the bacterial
cytoplasm. In both the JE2 and SH1000 backgrounds, the mspA mutants had higher
levels of intracellular iron, indicated by increased sensitivity to streptonigrin compared
to their wild-type strains (Fig. 4a to g).
In the mspA mutant, while the increased abundance of the Isd heme uptake system
proteins might explain the observed increased levels of intracellular iron, this system is
specific to heme, and tryptic soy broth (TSB), the medium used to grow the bacteria,
contains negligible amounts of this complex. The Hrt efflux system is also highly
specific for heme; that we see increased expression of this suggests that it is responding
to the increased levels of heme-iron produced endogenously by the bacteria. However,
FIG 2 Legend (Continued)
S. aureus backgrounds. The survival phenotype was complemented in both backgrounds by expressing the mspA gene
from a plasmid (pmspA). (d and e) Survival of S. aureus upon exposure to the human neutrophil defensin-1 (hNP-1) was
reduced in the mspA mutants in both S. aureus backgrounds, and this phenotype was complemented in both backgrounds
by expressing the mspA gene from a plasmid (pmspA). (f) Survival of S. aureus following phagocytosis is reduced in the
mspA mutants in both S. aureus backgrounds. (g) Survival in human blood is reduced in the absence of mspA in both
backgrounds. The dots represent biological replicates, the bars represent the means from the replicates, and the error bars
are the standard errors of the means. Statistics were performed using a one-way ANOVA, and significance was determined
as the following P values: *, 0.05; **, 0.01; ***, 0.001; ****, 0.0001; ns, not significant.
FIG 3 Inactivation of MspA affects membrane stability. (a) Membrane stability was determined by quantifying the
sensitivity of the bacteria to the detergent SDS, where the mspA mutant was significantly impaired. The sensitivity
of mutants with transposons in crtM, floA, and agrA was unaffected and is provided for comparison. Means from
three independent biological experiments are shown, and the error bars represent the standard errors of the
means. Statistics were performed using a one-way ANOVA, and significance was determined as the following P
values: *, 0.05; **, 0.01; ***, 0.001. (b and c) The MspA protein inhibits the penetration of the bacterial membrane
by propidium iodide. Wild-type and mspA mutant cells in the JE2 (b) and SH1000 (c) backgrounds were incubated
with PI, and the fluorescence of the cells was analyzed by flow cytometry. The shift of the peak to the right for the
mspA mutants demonstrates an increased PI signal, indicating that PI was better able to penetrate these cells and
stain the DNA. Representative images from three independent experiments are shown.
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as its function is to pump heme out of the cells, our seeing an increased iron level
despite increased expression of this efflux system suggests that its activity is impaired.
Interference in the stoichiometry of ATPases and their permeases has been shown
previously to significantly affect the activity of S. aureus efflux systems (36). In the mspA
mutant, we see an almost 18-fold increased abundance of the HrtB protein (the
permease) but only a 2.7-fold increased abundance of the HrtA protein (the ATPase),
which is intriguing, given that these genes are cotranscribed. Therefore, the observed
differences in relative abundance of the Hrt proteins may affect their efflux activity,
which, consequently, would affect the ability of the bacteria to reduce their intracellular
heme levels.
To examine whether the activity of the Hrt system was impaired in the mspA mutant
despite the HrtA and HrtB proteins being more abundant, we developed a heme
adaptation assay. The bacteria were grown overnight in either TSB or TSB supple-
mented with hemin, and these bacteria then were used to inoculate fresh TSB with
increasing concentrations of hemin, where bacterial adaptation to hemin was deter-
mined by quantifying their density after 8 h of growth (Fig. 5a). Preexposure of the
bacteria to hemin (in the overnight cultures) enabled the wild-type bacteria to adapt to
the increasing concentrations of hemin, as illustrated by the higher density of the
bacterial cultures after 8 h of growth (for both JE2 and SH1000 wild-type strains at
40 M, P  0.01) (Fig. 5b and c). However, in both backgrounds, the mspA mutants were
FIG 4 mspA mutants contain higher levels of intracellular iron. (a to d) Resistance to streptonigin was used to compare the level of intracellular iron in the mspA
mutants. Streptonigrin (1.5 l at a concentration of 2.5 mg/ml) was spotted onto a lawn of JE2 (a), JE2 mspA::tn (b), SH1000 (c), and SH1000 mspA::tn (d) cells,
and the plates were incubated to allow the bacteria to grow. The zone of clearance as a result of the diffusion of the antibiotic was larger for both mspA mutants,
suggesting they contain higher levels of intracellular iron. Representative images from three independent experiments are shown. (e to g) The effect of
streptonigrin was also determined in broth, where bacterial growth was determined after 8 h in increasing concentrations of streptonigrin. A mutant with a
transposon in the ferric uptake regulator (fur) in the JE2 background was included as a control. Streptonigrin was consistently more effective at inhibiting the
growth of the mspA mutant strains. Means from six independent biological experiments are shown, and error bars represent the standard errors of the means.
Statistics were performed using Student’s paired t test, and significance was determined as the following P values: *, 0.05; **, 0.01; ***, 0.001; ****, 0.0001.
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FIG 5 Ability of S. aureus to adapt to hemin is affected by the loss of MspA. (a) Illustration of our hemin
adaptation assay. Bacteria were cultured either in normal TSB or in TSB supplemented with 10 M hemin.
Bacteria then were subcultured into a range of hemin concentrations (40, 20, 10, 2.5, and 0 M).
Schematic was prepared on BioRender. (b and c) Preculture in hemin conferred an advantage for
subsequent growth in high hemin concentrations in both JE2 (b) and SH1000 (c) backgrounds. O/N,
overnight. The loss of mspA was disadvantageous for adaption to high hemin environments compared
to that of the wild-type strains. Means from six independent biological experiments are shown, and error
bars represent the standard errors of the means.
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impaired in their ability to adapt to the presence of hemin relative to the growth of the
wild-type strain (for both JE2 and SH1000 backgrounds at 40 M, P  0.01). This
suggests that despite the increased abundance of the Hrt proteins, the efflux activity of
this system is impaired, which provides an explanation for the increased intracellular
iron concentrations observed (Fig. 4a to f).
Increased intracellular hemin phenocopies the effects of the loss of MspA.
Previous work on the Hrt system, the major iron efflux system of S. aureus, demon-
strated that increased intracellular iron can affect what proteins the bacteria secrete
(37). As such, we sought to determine whether the increased levels of iron that result
from the loss of MspA (Fig. 4) contributes to the loss of toxicity and immune evasion
capabilities of the mutants. To address this, we grew the wild-type JE2 and SH1000
strains in TSB with increasing concentrations of hemin, where 10 M was the highest
concentration we could use that did not affect bacterial growth rates. We harvested the
bacterial supernatant and found that increasing levels of hemin resulted in decreased
cytolytic activity, as measured by THP-1 lysis (Fig. 6a and b). We also verified that, as
with the MspA mutant, the effect the increased iron had on toxicity was mediated
through the repression or lack of activation of the Agr quorum-sensing system (Fig. 6c
and d). Increased levels of intracellular iron also affected the level of staphyloxanthin
produced by the bacteria (Fig. 6e and f) and increased the permeability of the bacteria
to propidium iodide (Fig. 6g and h). Together, these data suggest that the effect the
loss of MspA has on iron homeostasis contributes to the effect we have observed on its
offensive and defensive capabilities.
Without MspA, S. aureus is unable to cause disease in either superficial or
invasive murine models of infection. The loss of the Agr system has been shown in
several models of infection to attenuate the pathogenicity of S. aureus (38–40). How-
ever, without MspA, S. aureus strains are not only impaired in the activation of the Agr
system but also less able to protect themselves from host immunity and to regulate
their intracellular iron levels. To examine the effect these pleiotropic effects have in
vivo, we utilized a murine subcutaneous infection model and compared the mspA
mutant to both the wild-type JE2 strain and an agrB mutant. Photographs of the
appearance of the abscesses were captured daily (Fig. 7a), and both the bacterial
density in skin punch biopsy specimens (Fig. 7b) and the abscess lesion area (Fig. 7c)
were compared for all three strains. As demonstrated previously (38–40), the loss of the
Agr system significantly attenuates the ability of S. aureus to cause infection. However,
the mspA mutant was significantly more attenuated than the agrB mutant in terms of
both abscess lesion area and tissue bacterial burden in our murine subcutaneous
infection model, demonstrating the considerable effect the loss of offensive, defensive,
and nutritional capacities has on pathogenicity in vivo.
We also compared the pathogenicity of the mspA mutant in a murine sepsis model,
as although the vast majority of infections caused by S. aureus are superficial skin and
soft-tissue infections, invasive diseases, such as sepsis, cause the most concern due to
the associated morbidity and mortality. Six and 24 h following sublethal tail vein
inoculation of C57BL/6J mice, the density of bacteria in blood, kidneys, and spleen was
quantified. In blood after 6 h, both the agrB and mspA mutants were more effectively
cleared than the wild-type strain, and by 24 h all three strains were barely detectable
(Fig. 7d). In both the spleens and livers at both 6 h and 24 h postinfection, the wild-type
strain was more abundant, and comparable bacterial burdens were detected for the
mspA and agrB mutant strains (Fig. 7e and f). In the kidneys at 6 h postinfection, both
the wild type and agr mutant were present at similar levels; however, we were unable
to detect any mspA mutant cells. By 24 h in the kidneys, we were able to detect the
mspA mutant, and it was at a burden equivalent to that of the agr mutant; however,
both mutants were at a significantly lower level than the wild-type strain (Fig. 7g). This
suggests that both mutants were impaired in their ability to establish an infection in the
kidney, where the mspA mutant appears to have a greater impairment in its ability to
disseminate to the kidneys during the early stages of infection. At this point, we feel an
experiment focused specifically on early kidney dissemination is required before any
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FIG 6 Increased intracellular hemin phenocopies the effects of the loss of MspA. When cultured in increasing
concentrations of hemin, the ability of JE2 (a) and SH1000 (b) to cause toxicity in THP-1 cells is diminished in a
concentration-dependent manner. (c and d) Transcript levels of RNAIII are, compared to levels of mspA-deficient JE2
and SH1000, further reduced in both backgrounds when exposed to hemin. (e and f) Carotenoid biosynthesis is also
reduced during culture with hemin, and this effect was observed in a concentration-dependent manner in both
backgrounds. (g and h) A shift in the PI staining for JE2 and SH1000 when cultured with hemin suggests that this
also affects membrane integrity. Representative images from three independent flow cytometry analyses are
shown. The dots represent biological replicates, the bars represent the means from the replicates, and the error
bars are the standard errors of the means. Statistics were performed using a one-way ANOVA, and significance was
determined as the following P values: *, 0.05; **, 0.01; ***, 0.001; ****, 0.0001.
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FIG 7 Inactivation of mspA affects the ability of S. aureus to cause disease in both a superficial and systemic infection
model. BALB/c mice were infected subcutaneously with 2  107 CFU wild-type (JE2) and isogenic strains in which the
(Continued on next page)
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firm conclusions can be drawn from our observations, as this could be due to differ-
ences in virulence, tissue tropism, or dissemination as a consequence of any (or all) of
the effects the loss of mspA has on toxin production, immune evasion, or iron
homeostasis.
DISCUSSION
S. aureus is a highly adaptable organism that is both a member of the human
microbiome, colonizing the nares of up to 30% of healthy populations, and also cause
disease in both healthy and immunocompromised individuals (1, 2). If novel means of
controlling infection are to be developed, we need a better understanding of its
pathogenicity. Through the application of a functional genomics approach to address
this, we identified a membrane protein central to the pathogenicity of S. aureus. This
protein, MspA, has a relatively small size of 105 amino acids, with only 28 residues
predicted to sit outside the bacterial membrane (Fig. 1h). Despite its diminutive status,
its loss has pleiotropic effects for which we have created a pictorial summary (Fig. 8).
Its loss affects S. aureus offensive (Fig. 1), defensive (Fig. 2 and 3), and nutritional
capabilities (Fig. 4 and 5), which together render the bacteria incapable of causing
infection (Fig. 7). Although we have yet to uncover the mechanistic detail of how this
small protein has such a wide-ranging impact, our data suggest that some of the effects
the loss of MspA has are a result of the increased level of heme in the cytoplasm of the
mspA mutant.
As we continue to study this protein to understand the molecular details of its
FIG 7 Legend (Continued)
mspA and agrB genes were inactivated. (a) Abscess lesion area was assessed daily, with representative lesions from the
dorsal area of mice from each group shown. (b) The bacterial burden in the skin was assessed by viable counting
(CFU/mg) at 3 and 6 days postinfection. (c) Abscess lesion area from panel a expressed as total lesion size (cm2)  SEM.
(d to g) Mice were inoculated via tail vein injection of 2  107 CFU the wild-type JE2 S. aureus strain and the mspA and
agrB mutants. The tail vein of C57BL/6J mice was inoculated with a sublethal dose of the wild-type JE2 S. aureus. Blood
(d), spleens (e), livers (f), and kidneys (g) were harvested at 6 and 24 h postinfection, and the burden of bacteria in each
sample was quantified. For the superficial infection, n  10, representative of 2 independent pooled experiments. For
the systemic infection, n  5 from one independent experiment. Statistics were performed using a one-way ANOVA
with a Tukey posttest (superficial) and Sidak’s multiple-comparison test (systemic), and significance was determined as
the following P values: *, 0.05; **, 0.01; ***, 0.001; ****, 0.0001.
FIG 8 Summary of the effect inactivation of the mspA gene has on the bacterial cell. In the absence of MspA, the
bacteria are unable to withstand membrane attack and phagocytosis. The Agr system does not become activated,
which subsequently affects the production of cytolytic toxins. The abundance and stoichiometry of the Hrt proteins
are also affected in the mspA mutant, which affects heme-iron homeostasis, and this may contribute to the toxicity
and immune susceptibility phenotypes reported here.
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activity, we have developed two working hypotheses. The first is that MspA directly
interacts in some way with the iron homeostasis systems of S. aureus. Our proteomic
data showed that the protein subunits of the heme efflux system Hrt were more
abundant in the mutant. While increased abundance of a protein is more typically
associated with increased activity, here we see the opposite, that the mutant bacteria
are less well able to adapt to the toxic effects of hemin. Perhaps MspA physically
interacts with these proteins, facilitating their efflux of heme from the cytoplasm.
Alternatively, MspA may have a direct structural role in stabilizing the bacterial mem-
brane, such that those proteins that require a certain amount of stability of the
membrane cannot function effectively without it. This instability could affect the
presentation or accessibility of proteins within the membrane, which might explain
why the Hrt and Agr systems are inactive. To test these hypotheses, we are searching
for proteins that directly interact with MspA; however, the highly hydrophobic nature
of this protein is such that working with any purified forms of it is proving challenging.
National surveillances of S. aureus are reporting year-on-year increases in the
incidence of invasive infections (4–6). Given the ability of S. aureus to develop resistance
to new antibiotics, alongside our inability to develop an effective vaccine, we need a
greater understanding of the fundamental biology of this organism if we are to develop
novel therapeutic approaches. Here, we have begun this process, and although the
mechanistic detail of MspA activity is not fully established, we highlight the pleiotropic
effect its loss has on S. aureus virulence, underlining its potential as a therapeutic target.
Encouragingly, recent work by Koch et al. (41) has highlighted the use of small-
molecule inhibitors to disrupt membrane protein function, successfully attenuating
virulence and reducing mortality in murine models of infection. With further work it is
possible that we could identify means of repressing MspA production, which would
completely incapacitate the bacteria, rendering it susceptible to immune clearance. As
such, this work not only represents a leap in our understanding of a core aspect of the
biology of S. aureus but also has identified a potential target for future therapeutic
development.
MATERIALS AND METHODS
Ethics statement. Peripheral blood from healthy donors was acquired in accordance with the
Declaration of Helsinki and approved by the Research Ethics Committee (REC 18/EE/0265). All animal
experiments were conducted in accordance with the recommendations and guidelines of the health
product regulatory authority (HPRA), the competent authority in Ireland, and in accordance with
protocols approved by Trinity College Dublin Animal Research Ethics Committee.
Bacterial strains and growth conditions. A list of S. aureus strains used in this study can be found
in Table 2. S. aureus strains were routinely grown in tryptic soy broth (TSB) or brain heart infusion (BHI),
where indicated. Overnight cultures were used to inoculate fresh media at a dilution of 1:1,000 and then
grown for 18 h at 37°C in air with shaking (180 rpm). For transposon mutants, erythromycin (5 g/ml) was
added to the growth medium. For complementation with pRMC2 plasmid (16) containing the mspA gene
(pmspA), anhydrous tetracycline (50 to 200 ng/ml) was included in the growth medium. The toxin-
containing supernatant for each bacterial strain was harvested by centrifugation at 10,000  g for 10 min.
Hemin (CAS 16009-13-5) and streptonigrin (CAS 3930-19-6) were included in culture media at the
indicated concentrations.
TABLE 2 Bacterial strains used in this study
Strain Description Reference
JE2 USA300; community-acquired MRSA, type IV SCCmec; lacking plasmids p01 and p03; wild-type
strain of the NTML
15
JE2 agrB::tn Accessory gene regulator B (agrB) transposon mutant in JE2 15
JE2 mspA::tn mspA transposon mutant in JE2 15
JE2 mspA::tn pmspA mspA transposon mutant complemented with mspA gene housed in pRMC2 expression plasmid This study
SH1000 Laboratory strain, 8325-4 with a repaired rsbU gene; SigB positive 17
SH1000 mspA::tn mspA transposon mutant in SH1000 This study
SH1000 mspA::tn pmspA mspA transposon mutant complemented with mspA gene housed in pRMC2 expression plasmid This study
JE2 crtM::tn Dehydrosqualene desaturase mutant in JE2 15
JE2 floA::tn Flotillin mutant in JE2 15
JE2 fur::tn Ferric uptake regulator mutant in JE2 15
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Genetic manipulations involving mspA. The mspA gene was amplified by PCR from JE2 using
Phusion high-fidelity DNA polymerase (NEB) and primers MspFW, CGGGTACCGAACCCTTTGAAACG (KpnI
is underlined; melting temperature [Tm], 64.2°C), and MspRV, GCGAGCTCGTTGCAATTATGTTATTGC (SacI
is underlined; Tm, 63.4°C), and cloned into the tetracycline-inducible plasmid pRMC2 to make pmspA. This
was electroporated into S. aureus RN4220 and subsequently into JE2 to complement the mspA trans-
poson mutant. DNA from JE2mspA::Tn was transduced into wild-type SH1000 by transduction with 11,
and transductants containing the inserted transposon were screened on tryptic soy agar (TSA) containing
erythromycin (10 g/ml). SH1000mspA::Tn was verified for Tn insertion of mspA by colony PCR using the
above-described mspA primers.
Monocyte (THP-1) toxicity. The monocytic THP-1 cell line (ATCC TIB-202) was used as previously
described (8, 9). Briefly, cells were grown in 30 ml of RPMI 1640 supplemented with heat-inactivated fetal
bovine serum (10%), L-glutamine (1 M), penicillin (200 U/ml), and streptomycin (0.1 mg/ml) (defined as
complete medium) in a humidified incubator at 37°C with 5% CO2. For toxicity assays, cells were
harvested by centrifugation at 400  g and resuspended to a final density of 1  106 to 1.5  106 cells/ml
in tissue-grade phosphate-buffered saline (PBS), typically yielding 95% viability. These were then
incubated for 10 min in the harvested supernatant of bacteria grown for 16 h in TSB (at a dilution of 30%
for the SH1000 strains and at 10% for the JE2 strains), and THP-1 cell death was quantified by trypan blue
exclusion and easyCyte flow cytometry. Experiments were performed in triplicate three times, and results
represent the means  standard deviations (SD).
Bronchial epithelial cell (A549) toxicity. A549 cells were grown in complete media. When confluent
(80 to 90%), cells were detached with trypsin EDTA (0.25%; ThermoFisher), resuspended, centrifuged for
10 min at 400  g, and resuspended to 1  106 to 1.5  106 cells/ml in tissue-grade PBS. To determine
S. aureus toxicity, 75 l of bacterial supernatant (bacterial grown overnight at 37°C in TSB) diluted to 25%
with fresh broth was incubated with 75 l of A549 cells in a 96-well plate for 20 min at 37°C. Cell lysis
was measured as lactate dehydrogenase release using the CytoTox 96 nonradioactive cytotoxicity assay
(Promega) according to the manufacturer’s instructions. Experiments were performed in triplicate three
times, and results represent the means  SD.
Human red blood corpuscle toxicity. Human red blood corpuscles (RBCs) were isolated from
heparinized venous blood obtained from healthy adult volunteers. RBCs were washed twice in sterile
saline (0.9% NaCl) and centrifuged at 600  g for 10 min. RBCs were diluted to 1% in PBS, and 200 l was
incubated with 50 l of bacterial supernatant in a 96-well plate for 30 min at 37°C. Plates were
centrifuged for 5 min at 400  g, supernatants were transferred to a sterile 96-well plate, and RBC lysis
was evaluated by determining the absorbance at 404 nm. Saline and 0.5% Triton X-100 were used as
negative and positive controls, respectively.
Toxin expression quantification. For Hla quantification, overnight cultures of S. aureus were diluted
1:1,000 in 5 ml TSB and incubated for 18 h at 37°C with shaking (180 rpm). Bacteria were normalized to
an optical density at 600 nm (OD600) of 2 and centrifuged for 10 min at 10,000  g, supernatant was
removed, and proteins were precipitated using trichloroacetic acid (TCA) at a 20% final concentration for
2 h on ice. Samples were centrifuged at 18,000  g for 20 min at 4°C, washed three times in ice-cold
acetone, and solubilized in 100 l 8 M urea. Proteins (10 l of each sample) were mixed with 2
concentrated sample buffer and heated at 95°C for 5 min before being subjected to 12% SDS-PAGE.
Separated proteins were wet transferred onto a nitrocellulose membrane and afterwards blocked
overnight in 5% semiskim milk at 4°C. Membranes were washed and incubated with polyclonal
antibodies specific for alpha-toxin (1:5,000 dilution; Sigma-Aldrich) for 2 h at room temperature.
Membranes were washed and incubated with horseradish peroxidase-coupled protein G (1:1,000;
Invitrogen) for 1 h at room temperature. Proteins were detected by using the Opti-4CN detection kit
(Bio-Rad). The Western blot analyses were performed in triplicate, and the bands were scanned and
quantified by using ImageJ software (http://rsbweb.nih.gov/ij/). Phenol-soluble modulin (PSM) quantifi-
cation, including delta toxin, was measured using reverse-phase high-performance liquid chromatogra-
phy/mass spectrometry (RP-HPLC/MS) as described previously (19).
Quantitative reverse transcription-PCR (qRT-PCR). Cultures of S. aureus grown overnight in TSB
were diluted 1:1,000 in fresh TSB and grown at 37°C for 7 h. Cultures were normalized based on OD600
measurements prior to RNA isolation. Cultures were treated with two volumes of RNAprotect (Qiagen),
incubated for 10 min at room temperature, and centrifuged, and the pellet was resuspended in Tris-EDTA
(TE) buffer (Ambion) with lysostaphin (5 mg/ml) and incubated for 1 h, followed by proteinase K
treatment for 30 min. RNA was isolated using the Quick-RNA kit (Zymo Research). RNA was quantified
using a NanoDrop (Thermo Fisher Scientific). Reverse transcription was performed using the qScript
cDNA synthesis kit QuantaBio) according to the manufacturer’s instructions using random primers.
Standard curves were generated for both sigA (forward, 5=-AACTGAATCCAAGTCATCTTAGTC-3=; reverse,
5=-TCATCACCTTGTTCAATACGTTTG-3=) and rnaIII (forward, 5=-GAAGGAGTGATTTCAATGGCACAAG-3=; re-
verse, 5=-TCATCACCTTGTTCAATACGTTTG-3=) primers using genomic DNA to determine efficiency. Real-
time PCR was performed using the SYBR green qPCR mix (NeoBiotech) and the Mic qPCR Cycler (Bio
Molecular Systems). Cycling conditions were 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and
60°C for 1 min and a dissociation step at 95°C for 15 s and 60°C for 1 min. Cycle threshold (CT) values were
determined for at least 3 biological repeats. For each reaction, the ratio of RNA III and sigA transcript
number was calculated as 2(CT RNAIII – CT sigA).
Protein extraction, TMT labeling, and high-pH reverse-phase chromatography. Bacteria were
cultured for 18 h in TSB, and 1 ml of this was pelleted by centrifugation and washed three times with
PBS. The pellet was resuspended in 200 l of PBS containing lysostaphin (200 g/ml), DNase I
(20 g/ml), and RNase (10 g/ml) and incubated at 37°C for 1 h. Insoluble debris was removed by
Duggan et al. Infection and Immunity
September 2020 Volume 88 Issue 9 e00162-20 iai.asm.org 16
 on S
eptem







centrifugation, and the samples were adjusted with PBS to a concentration of 2 mg/ml. Aliquots of
100 g (50 l) of the samples then were digested with trypsin (2.5 g trypsin per 100 g protein;
37°C, overnight) and labeled with TMT 10-plex reagents according to the manufacturer’s protocol
(Thermo Fisher Scientific), and the labeled samples were pooled. Each sample being differentially
labeled facilitates the analysis of multiple samples in parallel. To identify and quantify each protein
within the pooled labeled samples, an aliquot was evaporated to dryness and resuspended in buffer
A (20 mM ammonium hydroxide, pH 10) prior to fractionation by high-pH reverse-phase chroma-
tography using an Ultimate 3000 liquid chromatography system (Thermo Fisher Scientific). In brief,
the sample was loaded onto an XBridge BEH C18 column (130 Å, 3.5 m, 2.1 mm by 150 mm; Waters,
UK) in buffer A, and peptides were eluted with an increasing gradient of buffer B (20 mM ammonium
hydroxide in acetonitrile, pH 10) from 0% to 95% over 60 min. The resulting fractions were
evaporated to dryness and resuspended in 1% formic acid prior to analysis by nano-LC MS/MS using
an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific).
Nano-LC mass spectrometry. High-pH RP fractions were further fractionated using an Ultimate 3000
nanoHPLC system in line with an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific). In brief,
peptides in 1% (vol/vol) formic acid were injected onto an Acclaim PepMap C18 nanotrap column
(Thermo Scientific). After washing with 0.5% (vol/vol) acetonitrile, 0.1% (vol/vol) formic acid, peptides
were resolved on a 250-mm by 75-m Acclaim PepMap C18 reverse-phase analytical column (Thermo
Scientific) over a 150-min organic gradient, using seven gradient segments (1 to 6% solvent B over 1 min,
6 to 15% B over 58 min, 15 to 32% B over 58 min, 32 to 40% B over 5 min, 40 to 90% B over 1 min, held
at 90% B for 6 min and then reduced to 1% B over 1 min) at a flow rate of 300 nl min 1. Solvent A was
0.1% formic acid, and solvent B was aqueous 80% acetonitrile in 0.1% formic acid. Peptides were ionized
by nano-electrospray ionization at 2.0 kV using a stainless steel emitter with an internal diameter of
30 m (Thermo Scientific) and a capillary temperature of 275°C.
All spectra were acquired using an Orbitrap Fusion Tribrid mass spectrometer controlled by Xcalibur
2.0 software (Thermo Scientific) and operated in data-dependent acquisition mode using an SPS-MS3
workflow. FTMS1 spectra were collected at a resolution of 120,000 with an automatic gain control (AGC)
target of 200,000 and a maximum injection time of 50 ms. Precursors were filtered with an intensity
threshold of 5,000 according to charge state (to include charge states 2 to 7) and with monoisotopic
precursor selection. Previously interrogated precursors were excluded using a dynamic window (60
s  10 ppm). The MS2 precursors were isolated with a quadrupole mass filter set to a width of 1.2 m/z.
ITMS2 spectra were collected with an AGC target of 10,000, maximum injection time of 70 ms, and
collision-induced dissociation (CID) collision energy of 35%.
For FTMS3 analysis, the Orbitrap was operated at 50,000 resolution with an AGC target of 50,000
and a maximum injection time of 105 ms. Precursors were fragmented by high-energy collision
dissociation (HCD) at a normalized collision energy of 60% to ensure maximal TMT reporter ion yield.
Synchronous precursor selection (SPS) was enabled to include up to five MS2 fragment ions in the
FTMS3 scan.
Proteomic data analysis. The raw data files were processed and quantified using Proteome
Discoverer software v2.1 (Thermo Scientific) and searched against the UniProt Staphylococcus aureus
strain USA300 database (https://www.uniprot.org/taxonomy/451516) using the SEQUEST algorithm (42).
Peptide precursor mass tolerance was set at 10 ppm, and MS/MS tolerance was set at 0.6 Da. Search
criteria included oxidation of methionine (	15.9949) as a variable modification and carbamidomethy-
lation of cysteine (	57.0214), the addition of the TMT mass tag (	 229.163) to peptide N termini, and
lysine as fixed modifications. Searches were performed with full tryptic digestion, and a maximum of two
missed cleavages was allowed. The reverse database search option was enabled, and all peptide data
were filtered to satisfy a false discovery rate of 5%.
Carotenoid pigment analysis. Carotenoid pigment analysis was performed as described previously
(43), with minor modifications. Overnight bacterial cultures were used to inoculate 2 ml of fresh TSB in
a 1:1,000 dilution, which was subsequently grown for 24 h at 37°C with shaking (180 rpm). Eight hundred
fifty microliters of bacterial culture was centrifuged at 10,000  g for 4 min, supernatant was discarded,
and cells were resuspended in 100% methanol. Cells were heated for 3 min at 55°C in a water bath and
centrifuged at 10,000  g for 2 min to remove cell debris, and extraction was repeated twice. The
absorbance of the methanol extracts was measured at 453 nm using a photometer (GeneSpec III;
Hitachi). JE2 crtM::Tn was used as a negative control.
Oleic acid susceptibility. Bacteria were grown overnight, subcultured 1:1,000 in fresh TSB, and
grown for 18 h. Bacteria were washed twice in 2 M NaCl–2mM EDTA buffer, normalized to an OD600 of
1, and further diluted 1:1,000 in this buffer. Oleic acid (Sigma) was initially dissolved in ethanol, and a
working solution was further prepared in 2 M NaCl-2mM EDTA buffer. One hundred microliters of cells
was incubated with either 100 l of buffer or oleic acid solution (6 g/ml final concentration) in duplicate
for 1 h at 37°C. Bacteria were enumerated following dilution in PBS and plating onto TSA. Bacterial
survival was calculated by dividing the number of bacteria from wells containing oleic acid by bacteria
from wells containing the control.
Antimicrobial peptide susceptibility. The human neutrophil defensin-1 (hNP-1) (AnaSpec Incor-
porated, CA, USA) susceptibility assay was performed as described previously (15). Briefly, a final
inoculum of 105 CFU was resuspended in 1% BHI supplemented with 10 mM potassium phosphate
buffer and a final concentration of 5 g/ml of hNP-1 and incubated for 2 h at 37°C. Final bacterial
concentration was evaluated by serial plating onto TSA plates, and data are represented as mean
(SD) percent survival of CFU.
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Streptonigrin agar and broth susceptibility assay. For the agar assay normalized OD600, overnight
cultures were diluted 1:100 in PBS, and 100 l was mixed with 3 ml 0.5% agar and poured over TSA
plates. When dry, 1.5 l of streptonigrin (2.5 mg/ml; dissolved in dimethyl sulfoxide) was spotted onto
the plate. Plates were incubated at 37°C for 18 h, and zones of clearance were measured. Data are
represented as areas of growth inhibition. For the broth assays, normalized overnight cultures were
diluted 1:1,000, and 10 l of this was used to inoculate 5 ml of TSB containing increasing concentrations
of streptonigrin (0, 0.075, 0.25, 0.5, and 1 g/ml). The relative sensitivity of the bacteria to streptonigrin,
as a proxy for intracellular iron levels, was determined by quantifying bacterial growth (OD600) after 8 h
of incubation at 37°C.
Phagocytosis assay. THP-1 cells were harvested by centrifugation and resuspended in fresh com-
plete medium to 2  105 cells/ml. Monocytes were differentiated by the addition of phorbol 12-myristate
13-acetate (PMA) at a final concentration of 100 nM, and 500 l of cells was added to a tissue
culture-treated 24-well plate (Nunc) for 48 h. THP-1 cells were washed twice in tissue-grade PBS and
incubated with complete medium 24 h before infection. Two hours before infection, THP-1 cells were
washed twice in PBS and incubated in complete medium without antibiotics. Bacterial strains were
grown overnight, diluted 1:100 in fresh TSB, and grown to an OD of 0.3. Bacterial cells were washed twice
in PBS, and a multiplicity of infection of 1 was established to infect THP-1 cells. Plates were centrifuged
at 300  g for 5 min to synchronize phagocytosis and incubated at 37°C with 5% CO2 for 1 h. Following
1 h of incubation, medium was discarded, cells were washed four times in PBS, and wells were incubated
with RPMI medium containing gentamicin (200 g/ml) and lystostaphin (20 g/ml) for 1 h. Medium was
discarded, wells for 2-h time points were lysed with Triton X-100 (0.01%) and CFU enumerated on TSA
plates, and wells for analysis at 6 h were further incubated in RPMI containing no antibiotics and
processed as described above.
Human blood survival assay. Blood was collected from healthy volunteers and anticoagulated with
citrate. Bacterial cells were cultured to stationary phase for 18 h, diluted 1:100 in fresh TSB, and grown
to an OD600 of 0.6. Bacteria were washed in PBS three times, and 1  106 cells were inoculated into 1 ml
blood and incubated at 37°C for 60 min with gentle rotation. Serial dilutions were plated on TSA to
determine the number of CFU. The same number of bacterial cells inoculated into PBS and diluted and
plated immediately acted as a control. Survival was determined as the percentage of CFU in blood
relative to the PBS control.
SDS stability. The S. aureus strains were grown overnight in TSB and used at a 1:1,000 dilution to
inoculate TSB containing a range of concentrations of sodium dodecyl sulfate (Sigma). The ability of the
bacteria to withstand the membrane-damaging effect of the detergents was determined by quantifying
bacterial growth (OD600) after 24 h using a SPECTROstar Nano plate reader (BMG Labtech).
PI permeability assay. Membrane stability was determined as previously described (44, 45). The S.
aureus strains were grown overnight in TSB. Cells were harvested by centrifugation and resuspended in
PBS to a concentration of 1  106 cells per ml. One hundred microliters of bacterial cells was incubated
with propidium iodide (PI) for 5 min at room temperature prior to flow cytometric analysis on a Novocyte
(ACEA Biosciences). Data were analyzed using FlowJo 10.5.
Mice. Age (6 to 8 weeks)- and sex-matched wild-type BALB/c and C57BL/6J mice were purchased
from Charles River Laboratories UK. Mice were housed under specific-pathogen-free conditions at the
Trinity College Dublin Comparative Medicines unit. All animal experiments were conducted in accor-
dance with the recommendations and guidelines of the health product regulatory authority (HPRA), the
competent authority in Ireland, and in accordance with protocols approved by Trinity College Dublin
Animal Research Ethics Committee.
Murine subcutaneous abscess model. The dorsal backs of mice were shaved and injected subcu-
taneously with S. aureus (2  107 CFU) in 100 l of sterile PBS using a 27-gauge syringe (BD Biosciences).
Measurements of abscess lesion area (in square centimeters) were made by analyzing digital photo-
graphs using M3 Vision software (Biospace Lab), and pictures contain a millimeter ruler as a reference.
To determine the bacterial burden, 8-mm punch biopsy specimens of lesional skin were taken at days 3
and 6 postinfection. Tissue was homogenized in sterile PBS, and total bacterial burden was determined
by plating out serial dilutions on TSA.
Murine bloodstream infection model. A total of 5  107 cells of the JE2, JE2mspA::tn, or JE2agrB::tn
strain was used via tail vein injection. Mice were culled at 6 and 24 h. Blood was collected by cardiac
puncture. Liver, spleen, and kidney were harvested and homogenized in 1 ml of PBS. Bacterial burdens
were established by plating out serial dilutions of blood and organ homogenates on TSA.
Statistics. Paired two-tailed Student’s t test or one-way analysis of variance (ANOVA) (GraphPad
Prism v5.0) were used to analyze the observed differences between experimental results. A P value of
0.05 was considered statistically significant. For in vivo studies, two-way ANOVA with Tukey posttest or
Sidak’s multiple-comparison test were used to analyze differences between groups.
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